bluebird focuses on developing transformative gene therapies for severe genetic diseases and cancer...
Read morebluebird focuses on developing transformative gene therapies for severe genetic diseases and cancer...
Read moreAnnual Revenue
$5.1M
bluebird bio's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 4.7B. Over the last two quarters, bluebird bio's revenue has decreased by 21.9%. Specifically, in Q2 2022's revenue was $1.5M; in Q1 2022, it was $1.9M.